Analyses of Risk for Liver Injury Associated with Dipeptidyl Peptidase-4 Inhibitors and of Influence of Co-administered Drugs on Vildagliptin-induced Liver Injury Using the Japanese Adverse Drug Event Report (JADER) Database

Abstract

[in Japanese]